Meta-analysis of randomized trials of glycoprotein IIb/IIIa inhibitors in high-risk acute coronary syndromes patients undergoing invasive strategy

American Journal of Cardiology

Volumn 107, Issue 2, 2011, Pages 198-203

  De Luca, Giuseppe ^a   Navarese, Eliano Pio ^a   Cassetti, Ettore ^a   Verdoia, Monica ^a   Suryapranata, Harry ^b  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b HOSPITAL DE WEEZENLANDEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; CLOPIDOGREL; EPTIFIBATIDE; HEPARIN; HIRULOG; TIROFIBAN;

ACUTE CORONARY SYNDROME; ARTICLE; BLEEDING; CONTROLLED STUDY; DRUG FATALITY; DRUG MEGADOSE; HEART INFARCTION; HEMATOMA; HUMAN; INVASIVE PROCEDURE; LOADING DRUG DOSE; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REVASCULARIZATION; SIDE EFFECT; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACUTE CORONARY SYNDROME; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MYOCARDIAL REVASCULARIZATION; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 78650884677     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.08.063     Document Type: Article

References (19)

1. J.L. Anderson, C.D. Adams, E.M. Antman, C.R. Bridges, R.M. Califf, D.E. Casey Jr, W.E. Chavey II, F.M. Fesmire, J.S. Hochman, T.N. Levin, A.M. Lincoff, E.D. Peterson, P. Theroux, N.K. Wenger, R.S. Wright, S.C. Smith Jr, A.K. Jacobs, C.D. Adams, J.L. Anderson, E.M. Antman, J.L. Halperin, S.A. Hunt, H.M. Krumholz, F.G. Kushner, B.W. Lytle, R. Nishimura, J.P. Ornato, R.L. Page, and B. Riegel ACC/AHA 2007 guidelines for the management of patients with unstable angina/nonST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/NonST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine J Am Coll Cardiol 50 suppl 2007 e1 e157 (erratum. J Am Coll Cardiol 2008;51:974)
2. J.P. Bassand, C.W. Hamm, D. Ardissino, E. Boersma, A. Budaj, F. Fernndez-Avils, K.A. Fox, D. Hasdai, E.M. Ohman, L. Wallentin, and W. Wijns Guidelines for the diagnosis and treatment of nonST-segment elevation acute coronary syndromes Eur Heart J 28 2007 1598 1660
3. The Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina N Engl J Med 338 1998 1498 1505
4. The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and nonQ-wave myocardial infarction N Engl J Med 338 1998 1488 1497
5. The PURSUIT Trial Investigators Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes N Engl J Med 339 1998 436 443
6. E. Boersma, R.A. Harrington, D.J. Moliterno, H. White, P. Throux, F. Van de Werf, A. de Torbal, P.W. Armstrong, L.C. Wallentin, R.G. Wilcox, J. Simes, R.M. Califf, E.J. Topol, and M.L. Simoons Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials Lancet 359 2002 189 198
7. D. Moher, D.J. Cook, S. Eastwood, I. Olkin, D. Rennie, and D.F. Stroup Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement Quality of Reporting of Meta-analyses Lancet 354 1999 1896 1900
8. L. Bolognese, G. Falsini, F. Liistro, P. Angioli, K. Ducci, T. Taddei, R. Tarducci, F. Cosmi, S. Baldassarre, and A. Burali Randomized comparison of upstream tirofiban versus downstream high bolus dose tirofiban or abciximab on tissue-level perfusion and troponin release in high-risk acute coronary syndromes treated with percutaneous coronary interventions: the EVEREST trial J Am Coll Cardiol 47 2006 522 528
9. E. Durand, C.W. Hamm, C.M. Macaya, J.L. Georges, P. Coste, J.E. Wolf, M.S. Slama, S.E. Husted, M. Mosseri, and A. Lafont A randomised controlled trial of upstream administration of eptifibatide in patients presenting nonST segment elevation acute coronary syndrome treated with an invasive strategy EuroIntervention 3 2007 228 234
10. R.P. Giugliano, L.K. Newby, R.A. Harrington, C.M. Gibson, F. Van de Werf, P. Armstrong, G. Montalescot, J. Gilbert, J.T. Strony, R.M. Califf, E. Braunwald EARLY ACS Steering Committee The Early Glycoprotein IIb/IIIa Inhibition in NonST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial: a randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with nonST-segment elevation acute coronary syndromestudy design and rationale Am Heart J 149 2005 994 1002
11. M. Leoncini, A. Toso, M. Maioli, F. Bellandi, T. Badia, A. Politi, S. De Servi, and R.P. Dabizzi Effects of tirofiban plus clopidogrel versus clopidogrel plus provisional abciximab on biomarkers of myocardial necrosis in patients with nonST-elevation acute coronary syndromes treated with early aggressive approach Results of the CLOpidogrel, upstream TIrofiban, in cath Lab Downstream Abciximab (CLOTILDA) study Am Heart J 150 2005 401 406
12. T. Liu, Y. Xie, Y.J. Zhou, Y.P. Li, H.Y. Ma, Y.H. Guo, Y.Y. Liu, Y.X. Zhao, and D.M. Shi Effects of upstream tirofiban versus downstream tirofiban on myocardial damage and 180-day clinical outcomes in high-risk acute coronary syndromes patients undergoing percutaneous coronary interventions Chin Med J 122 2009 1732 1737
13. F.J. Neumann, A. Kastrati, G. Pogatsa-Murray, J. Mehilli, H. Bollwein, H.P. Bestehorn, C. Schmitt, M. Seyfarth, J. Dirschinger, and A. Schmig Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial JAMA 290 2003 1593 1599
14. M.T. Roe, R.H. Christenson, E.M. Ohman, R. Bahr, F.M. Fesmire, A. Storrow, M. Mollod, W.F. Peacock, J.A. Rosenblatt, H. Yang, E.S. Fraulo, J.W. Hoekstra, W.B. Gibler EARLY Investigators; Emergency Medicine Cardiac Research and Education Group A randomized, placebo-controlled trial of early eptifibatide for nonST-segment elevation acute coronary syndromes Am Heart J 146 2003 993 998
15. G.W. Stone, M.E. Bertrand, J.W. Moses, E.M. Ohman, A.M. Lincoff, J.H. Ware, S.J. Pocock, B.T. McLaurin, D.A. Cox, M.Z. Jafar, H. Chandna, F. Hartmann, F. Leisch, R.H. Strasser, M. Desaga, T.D. Stuckey, R.B. Zelman, I.H. Lieber, D.J. Cohen, R. Mehran, H.D. White ACUITY Investigators Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing Trial JAMA 297 2007 591 602
16. A.W. van't Hof, S.T. de Vries, J.H. Dambrink, K. Miedema, H. Suryapranata, J.C. Hoorntje, A.T. Gosselink, F. Zijlstra, and M.J. de Boer A comparison of two invasive strategies in patients with nonST elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study 2b/3a upstream therapy and acute coronary syndromes Eur Heart J 24 2003 1401 1405
17. S. Rasoul, J.P. Ottervanger, M.J. de Boer, K. Miedema, J.C. Hoorntje, M. Gosselink, F. Zijlstra, H. Suryapranata, J.H. Dambrink, and A.W. van't Hof A comparison of dual vs. triple antiplatelet therapy in patients with nonST-segment elevation acute coronary syndrome: results of the ELISA-2 trial Eur Heart J 27 2006 1401 1407
18. S.D. Wiviott, E. Braunwald, C.H. McCabe, G. Montalescot, W. Ruzyllo, S. Gottlieb, F.J. Neumann, D. Ardissino, S. De Servi, S.A. Murphy, J. Riesmeyer, G. Weerakkody, C.M. Gibson, E.M. Antman TRITON-TIMI 38 Investigators Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015 (Pubitemid 350106708)
19. L. Wallentin, R.C. Becker, A. Budaj, C.P. Cannon, H. Emanuelsson, C. Held, J. Horrow, S. Husted, S. James, H. Katus, K.W. Mahaffey, B.M. Scirica, A. Skene, P.G. Steg, R.F. Storey, R.A. Harrington, A. Freij, M. Thorsn PLATO Investigators Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057